Literature DB >> 24078138

The state of the art of endothermal ablation.

Renate R van den Bos, Thomas M Proebstle.   

Abstract

Complaints relating to reflux in the venous system can be addressed by conservative, surgical, or interventional treatment options. The aim of the treatment is to prevent complications and progression of venous disease and to improve patients' quality of life. Endovenous thermal ablation therapies have become the most frequently used type of therapy for saphenous varicose veins. The available endovenous thermal techniques are endovenous laser ablation, radiofrequency ablation, and endovenous steam ablation. In this review, the procedures, indications, and treatment parameters of the three endovenous thermal ablation treatments are discussed as well as their advantages and disadvantages.

Entities:  

Mesh:

Year:  2014        PMID: 24078138     DOI: 10.1007/s10103-013-1448-5

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  34 in total

1.  Venous severity scoring: An adjunct to venous outcome assessment.

Authors:  R B Rutherford; F T Padberg; A J Comerota; R L Kistner; M H Meissner; G L Moneta
Journal:  J Vasc Surg       Date:  2000-06       Impact factor: 4.268

2.  Laser and radiofrequency ablation study (LARA study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm).

Authors:  S D Goode; A Chowdhury; M Crockett; A Beech; R Simpson; T Richards; B D Braithwaite
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-08       Impact factor: 7.069

3.  Evaluation of setpoint temperature and pullback speed on vein adventitial temperature during endovenous radiofrequency energy delivery in an in-vitro model.

Authors:  Arthur W Zikorus; Michael S Mirizzi
Journal:  Vasc Endovascular Surg       Date:  2004 Mar-Apr       Impact factor: 1.089

4.  The first 1000 cases of Italian Endovenous-laser Working Group (IEWG). Rationale, and long-term outcomes for the 1999-2003 period.

Authors:  G B Agus; S Mancini; G Magi
Journal:  Int Angiol       Date:  2006-06       Impact factor: 2.789

Review 5.  Endovenous laser therapy and radiofrequency ablation of saphenous varicose veins.

Authors:  F Pannier; E Rabe
Journal:  J Cardiovasc Surg (Torino)       Date:  2006-02       Impact factor: 1.888

6.  Comparison of 980 nm laser and bare-tip fibre with 1470 nm laser and radial fibre in the treatment of great saphenous vein varicosities: a prospective randomised clinical trial.

Authors:  S Doganci; U Demirkilic
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-05-23       Impact factor: 7.069

7.  Closure of the greater saphenous vein with endoluminal radiofrequency thermal heating of the vein wall in combination with ambulatory phlebectomy: preliminary 6-month follow-up.

Authors:  M P Goldman
Journal:  Dermatol Surg       Date:  2000-05       Impact factor: 3.398

8.  Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities.

Authors:  Thomas M Proebstle; Jens Alm; Oliver Göckeritz; Christian Wenzel; Thomas Noppeney; Christian Lebard; Olivier Pichot; Carmine Sessa; Denis Creton
Journal:  J Vasc Surg       Date:  2011-03-24       Impact factor: 4.268

Review 9.  Revision of the CEAP classification for chronic venous disorders: consensus statement.

Authors:  Bo Eklöf; Robert B Rutherford; John J Bergan; Patrick H Carpentier; Peter Gloviczki; Robert L Kistner; Mark H Meissner; Gregory L Moneta; Kenneth Myers; Frank T Padberg; Michel Perrin; C Vaughan Ruckley; Philip Coleridge Smith; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2004-12       Impact factor: 4.268

10.  Mathematical modeling of endovenous laser treatment (ELT).

Authors:  Serge R Mordon; Benjamin Wassmer; Jaouad Zemmouri
Journal:  Biomed Eng Online       Date:  2006-04-25       Impact factor: 2.819

View more
  1 in total

1.  Ins and outs of endovenous laser ablation: afterthoughts.

Authors:  H A Martino Neumann; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-01-08       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.